Literature DB >> 29404181

Association between the Serum Metabolic Profile and Lung Function in Chronic Obstructive Pulmonary Disease.

Shima Rafie1,2, Subhabrata Moitra3, Bill B Brashier4,2.   

Abstract

OBJECTIVES: Although dietary patterns are known to modulate disease severity in patients with chronic obstructive pulmonary disease (COPD), the relationship between the circulating lipid profile and lung function in COPD has not been studied extensively.
MATERIAL AND METHODS: There were 43 COPD patients with a history of smoking and 39 patients with a history of biomass fuel exposure recruited in this study, along with 43 age-matched healthy controls. All participants underwent complete lung function profiling, and their glucose and lipid profiles were measured. The association between the metabolic profile and lung function was assessed using the Spearman's rank-order correlation coefficient.
RESULTS: 52.4% of the COPD patients were smokers compared to the healthy group (46.5%). We found an inverse correlation between triglyceride and functional residual capacity (p=-0.21, p=0.05) and a positive association between serum cholesterol and overall airway resistance (R5) (p=0.24, p=0.04) and central airway resistance (R20) (p=0.32, p=0.004). Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) ratio and LDL/HDL ratio were also found to correlate with R5 (p=0.25, 0.23, and 0.22, respectively) and R20 (p=0.31, 0.24, and 0.24, respectively). No significant association was observed between other metabolites and either spirometric or plethysmographic lung function indices.
CONCLUSION: High serum triglyceride and cholesterol may increase the resistance in the airways, which may lead to increased airway obstruction. Therefore, monitoring of lipid profile should be considered in the diagnosis and management of COPD.

Entities:  

Keywords:  Airway resistance; COPD; lipid profile; lung function

Year:  2017        PMID: 29404181      PMCID: PMC5783048          DOI: 10.5152/TurkThoracJ.2017.17043

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  18 in total

Review 1.  Standardisation of the measurement of lung volumes.

Authors:  J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 3.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  The effects of body mass index on lung volumes.

Authors:  Richard L Jones; Mary-Magdalene U Nzekwu
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

6.  Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation.

Authors:  Ki-Hoon Park; Dong-Gu Shin; Kyung-Hyun Cho
Journal:  Toxicol Sci       Date:  2014-05-05       Impact factor: 4.849

7.  The effect of body fat distribution on pulmonary function tests.

Authors:  L C Collins; P D Hoberty; J F Walker; E C Fletcher; A N Peiris
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

8.  Plasma lipoproteins in chronic obstructive pulmonary disease.

Authors:  T Fekete; R Mösler
Journal:  Horm Metab Res       Date:  1987-12       Impact factor: 2.936

Review 9.  Obesity and the lung: 5. Obesity and COPD.

Authors:  F M E Franssen; D E O'Donnell; G H Goossens; E E Blaak; A M W J Schols
Journal:  Thorax       Date:  2008-12       Impact factor: 9.139

10.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  4 in total

1.  Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis.

Authors:  Lingling Xuan; Feifei Han; Lili Gong; Yali Lv; Zirui Wan; He Liu; Dongsu Zhang; Yangjie Jia; Song Yang; Lulu Ren; Lihong Liu
Journal:  Lipids Health Dis       Date:  2018-11-21       Impact factor: 3.876

2.  Egg and cholesterol consumption and mortality from cardiovascular and different causes in the United States: A population-based cohort study.

Authors:  Pan Zhuang; Fei Wu; Lei Mao; Fanghuan Zhu; Yiju Zhang; Xiaoqian Chen; Jingjing Jiao; Yu Zhang
Journal:  PLoS Med       Date:  2021-02-09       Impact factor: 11.069

Review 3.  High-Density Lipoproteins: A Role in Inflammation in COPD.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

Review 4.  The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.